UPC SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Jan 28, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Apr 29, 2025

NT 20-F

Form NT 20-F - Notification of inability to timely file Form 20-F

Jan 27, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Jan 30, 2024

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Feb 10, 2023

NT 20-F

Form NT 20-F - Notification of inability to timely file Form 20-F

Jan 30, 2023

News

TYPE

HEADLINE

FILED AT

6-K

Universe Pharmaceuticals INC. Announces Results of 2026 Annual General Meeting of Shareholders

Oct 6, 2026

6-K/A

Universe Pharmaceuticals INC Announces 2026 Annual General Meeting of Shareholders

Sep 3, 2026

6-K

Universe Pharmaceuticals INC Announces 2026 Annual General Meeting of Shareholders

Sep 1, 2026

6-K

Universe Pharmaceuticals INC Completes Acquisition of Best Praise International Limited

Jul 31, 2026

6-K

Universe Pharmaceuticals Inc. Reports Unaudited Financial Results for the Six Months Ended March 31, 2026

Jul 29, 2026

6-K

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

Jun 26, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Dec 9, 2024

424B4

OFFERING | Shares amount: 20,000,000 | Share price: $1.25

Jun 25, 2024

424B4

5,000,000 Ordinary Shares-

Mar 24, 2021

Registrations

TYPE

HEADLINE

FILED AT

F-3

September 2026 SHELF | SHARE RESALE REGISTRATION EFFECTIVE, DATED 2026-10-09

Sep 29, 2026

F-1/A

INITIAL REGISTRATION FOR OFFERING | Shares amount: 20,000,000 | Share price: $1.25 EFFECTIVE

May 14, 2024

F-1

INITIAL REGISTRATION FOR OFFERING | Shares amount: 20,000,000 | Share price: $1.25 EFFECTIVE

Apr 24, 2024

F-3

SHELF | Offering amount: $200,000,000.00 | Float: 9,270,000 | Amount sold to date: $0.00 EFFECTIVE

Oct 27, 2022

8-A12B

Registration

Mar 17, 2021

F-1/A

5,000,000 Ordinary Shares- EFFECTIVE

Mar 10, 2021

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

Chen Xuncheng (Filed by)

Sep 1, 2026

SCHEDULE 13G

Li Xuefeng (Filed by)

Sep 1, 2026

SCHEDULE 13G

Lu Shanshan (Filed by)

Sep 1, 2026

SCHEDULE 13G

Xie Shan (Filed by)

Sep 1, 2026

SCHEDULE 13G

Ye Piao (Filed by)

Sep 1, 2026

SCHEDULE 13G

Yang Lu (nmn) (Filed by)

Sep 1, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 13, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 10, 2024

CORRESP

Form CORRESP - Correspondence

Jun 5, 2024

CORRESP

Form CORRESP - Correspondence

May 14, 2024

LETTER

Form UPLOAD - SEC-generated letter

May 8, 2024

EFFECT

Form EFFECT - Notice of Effectiveness

Nov 16, 2022

Universe Pharmaceuticals Inc. UPC · SEC Filings